# A Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing Spondylitis

> **NCT02685904** · PHASE3 · TERMINATED · sponsor: **Mycenax Biotech Inc.** · enrollment: 10 (actual)

## Conditions studied

- Ankylosing Spondylitis

## Interventions

- **BIOLOGICAL:** ENIA11
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT02685904
- **Lead sponsor:** Mycenax Biotech Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-09-06
- **Primary completion:** 2018-01-28
- **Final completion:** 2018-12-31
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Sponsor's decision
- **Last updated:** 2019-03-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02685904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02685904, "A Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing Spondylitis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02685904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*